| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/15/2003 | EP1274399A1 Liposomes containing an entrapped compound in supersaturated solution |
| 01/15/2003 | EP1274398A2 Effervescent granules and methods for their preparation |
| 01/15/2003 | EP1274397A2 Drug delivery composition and device |
| 01/15/2003 | EP1274396A2 Device for applying active principles for pharmaceutical or cosmetic purposes |
| 01/15/2003 | EP1163007B1 Propofol formulation containing tris |
| 01/15/2003 | EP1156788B1 Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions |
| 01/15/2003 | EP1150643B1 Microemulsion containing alkano lammonium salts of fatty alcohol sulfates and/or alkylpoly alkylene glykol ether sulfates |
| 01/15/2003 | EP1121929A4 Drug preparation "histochrome" for treating ocular conditions |
| 01/15/2003 | EP1112064B1 Method for preparing novel fenofibrate galenic formulations, galenic formulations obtained and applications |
| 01/15/2003 | EP1104233B1 Improved film-forming compositions for protecting animal skin |
| 01/15/2003 | EP1063998B1 Medicament for preventing and/or treating a mammary carcinoma, containing a steroidal aromatase inhibitor |
| 01/15/2003 | EP1059933B1 Use of parathyroide hormone consisting of aminoacid sequence 1-34 of human parathyroid hormone for reducing the risk of both vertebral and non vertebral bone fracture |
| 01/15/2003 | EP1009524B1 Improvements in or relating to capsules |
| 01/15/2003 | EP0991405B1 Clear, injectable formulation of an anesthetic compound |
| 01/15/2003 | EP0977597B1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 01/15/2003 | EP0934093B1 System for delivery of drugs by transport |
| 01/15/2003 | EP0912166B1 Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients |
| 01/15/2003 | EP0857072B1 Implantable bioresorbable membrane and method for the preparation thereof |
| 01/15/2003 | EP0834314B1 Granules containing pranlukast, process for producing the granules, and method of lowering cohesiveness of pranlukast |
| 01/15/2003 | EP0778767B1 Delivery of solid drug compositions |
| 01/15/2003 | EP0769949B1 Hydromorphone therapy |
| 01/15/2003 | EP0730444B1 Sustained release formulations for 24 hour release of metoprolol |
| 01/15/2003 | EP0701436B1 Process |
| 01/15/2003 | EP0671927B1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/15/2003 | CN2530663Y Portable wet-dressing medicine pad |
| 01/15/2003 | CN2530641Y Integral wet application |
| 01/15/2003 | CN1391580A Peptides |
| 01/15/2003 | CN1391565A Benzophenones as inhibitors of reverse transcriptase |
| 01/15/2003 | CN1391490A Delivery system for therapy comprising hollow seeds, preferably metal, and use thereof |
| 01/15/2003 | CN1391485A Particulate vitamin composition |
| 01/15/2003 | CN1391483A Composition of octoxinol and polyvinyl chloride sorbitanate as accessory and uses in vaccins |
| 01/15/2003 | CN1391480A Compositions and methods for treatment of allergic disorders |
| 01/15/2003 | CN1391478A Aqueous solution formulation of alpha-interferon |
| 01/15/2003 | CN1391476A Vasopressin agonist formulation and process |
| 01/15/2003 | CN1391475A Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 01/15/2003 | CN1391472A Use of pleuromutilin derivatives for transdermal treatment of bacterial diseases |
| 01/15/2003 | CN1391467A Method of microencapsulation |
| 01/15/2003 | CN1391466A Vasopressin antagonist formulation and process |
| 01/15/2003 | CN1391465A 包衣 Coating |
| 01/15/2003 | CN1391464A Formulation for menopausal women |
| 01/15/2003 | CN1391463A Intranasal influenza virus vaccine |
| 01/15/2003 | CN1390878A Improved solid media |
| 01/15/2003 | CN1390593A Chinese-medicinal ointment for treating burn |
| 01/15/2003 | CN1390586A Plaster fr treating facial paralysis |
| 01/15/2003 | CN1390582A Crude drugs pastes |
| 01/15/2003 | CN1390562A Chinese medicine for treating burn and scald and its preparing process |
| 01/15/2003 | CN1390550A Freeze-dried minocycline hydrochloride powder injection and its preparing process |
| 01/15/2003 | CN1390542A Freeze-dried ginkgolide powder injection and its preparing process |
| 01/15/2003 | CN1390541A Naofusu |
| 01/15/2003 | CN1390538A Slow-releasing Wannailuowei hydrochloride tablet and its preparing process |
| 01/15/2003 | CN1390536A Process fr preparing submicron Dragon's blood powder |
| 01/15/2003 | CN1390534A Composition containing semicrystalized polymer gelled liquid fatty phase |
| 01/15/2003 | CN1098708C Pernasal composition and pernasal preparation containing the same |
| 01/15/2003 | CN1098705C Oral medicine for diseases of cranial nerves system and preparing method thereof |
| 01/15/2003 | CN1098699C Fushuixiao oral liquor (medicine for elimianting ascites) and preparing process |
| 01/15/2003 | CN1098698C Medicine for leukemia and its preparing method |
| 01/15/2003 | CN1098690C Microencapsulated bovine adrenal medulla chromaffincell medicine used for treating Parkinson's disease |
| 01/15/2003 | CN1098685C Rifampin film and preparing method and use thereof |
| 01/15/2003 | CN1098684C Orally administerable pharmaceutical formulations |
| 01/15/2003 | CN1098682C Pharmaceutical process of crocus sativus polyglycoside and its tablets |
| 01/15/2003 | CN1098681C Oil-in-water emulsion and its use and medicinal composition containing it |
| 01/15/2003 | CN1098680C Suspending liquid for spray and preparing method thereof |
| 01/15/2003 | CN1098679C Methods and compositions for pulmonary delivery of insulin |
| 01/15/2003 | CN1098678C Ophtalmic solution based on diclofenac and tobramicine and its application |
| 01/15/2003 | CN1098654C Kelp product and its production method and application |
| 01/14/2003 | US6506891 Cell surface molecule-induced macrophage activation |
| 01/14/2003 | US6506833 For use as stabilizers of emulsions and dispersions, and as slip agents in cosmetic and pharmaceutical solutions |
| 01/14/2003 | US6506803 Methods of preventing and treating microbial infections |
| 01/14/2003 | US6506753 Anxiolytic agents, anticonvulsants |
| 01/14/2003 | US6506742 Adding a contraceptive to ethyl alcohol, then adding a low molecular weight polyethylene glycol, and then adding water to give specified dosage; bioavailability, stability; useful as a reference standard |
| 01/14/2003 | US6506731 Elastin peptide analogs and methods of using same |
| 01/14/2003 | US6506730 Nasal transmucosal delivery of peptide conjugated with biocompatible polymers |
| 01/14/2003 | US6506549 Sodium, calcium, chloride, potassium, albumin, and sugar; plasmaphoresis |
| 01/14/2003 | US6506420 Combinations of psyllium and chitosan for synergistic adsorption of triglyceride |
| 01/14/2003 | US6506411 Anti-angiogenic compositions and methods of use |
| 01/14/2003 | US6506410 Sustained release microparticle and method for preparing the same |
| 01/14/2003 | US6506408 Implantable or insertable therapeutic agent delivery device |
| 01/14/2003 | US6506407 Drug coated with an organic acid-soluble polymer material and a saccharide,which rapidly generates an organic acid by the action enterobacteria |
| 01/14/2003 | US6506406 Reduces smell of feces |
| 01/14/2003 | US6506405 Methods and formulations of cremophor-free taxanes |
| 01/14/2003 | US6506404 Release of ibuprofen from hot melt adhesive compositions through addition of pharmaceutical auxiliaries |
| 01/14/2003 | US6506403 Treatment patch |
| 01/14/2003 | US6506400 Antiinfective free intramammary veterinary composition |
| 01/14/2003 | US6506399 Controlled release implantable drug delivery system composed of a plurality of botulinum toxin-incorporating polymeric microspheres. |
| 01/14/2003 | US6506394 Delivery of a botanical extract to a treated substrate for transfer to skin |
| 01/14/2003 | US6506393 Methods of treating protozoal diseases |
| 01/14/2003 | US6506381 Modified red blood cell that has surface molecules that neutralize chemical agents |
| 01/14/2003 | US6506378 Increasing efficiency of 3,4-dihydroxyphenylalanine conver-sion to dopamine; sequestering for sustained release; gene transfer modification of donor cells for grafting into central nervous system |
| 01/14/2003 | US6506262 Comprising: a liposome; and greater than about 40 weight percent of a solvent wherein the liposome is loaded with the solvent more than about 7 days after the manufacture of the liposome. |
| 01/14/2003 | CA2166301C Method and apparatus for the formation of particles |
| 01/14/2003 | CA2114629C Receptor conjugates for targeting antibiotics to bacteria |
| 01/14/2003 | CA2093258C Cytarabine ocfosfate hard capsule |
| 01/14/2003 | CA2067975C Buffered matrix aspirin tablet |
| 01/14/2003 | CA2065270C Erection-inducing methods and compositions |
| 01/14/2003 | CA2056322C Ginkgo biloba acting as alpha-2-blocker slimming compound |
| 01/09/2003 | WO2003003004A2 Method for identifying compounds the specifically deplete mast cells |
| 01/09/2003 | WO2003002710A2 Artificial synapse chip interface for electronic prosthetic retina |
| 01/09/2003 | WO2003002264A1 Dry powder electrostatic deposition method and apparatus |
| 01/09/2003 | WO2003002259A1 Process for activation of drugs in a vibrational mill |
| 01/09/2003 | WO2003002258A1 Drug activation process and vibrational mill therefor |